Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

v3.20.1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2020
Accounting Policies [Abstract]  
Schedule of antidilutive securities excluded from computation of earnings per share
    As of March 31,  
    2020     2019  
Common stock equivalents:            
Common stock options     307,202       381,412  
Series A, H-1, H-3, H-4, H-5, H-6, I, J, K and Merger common stock purchase warrants     4,300,560       585,306  
Series H, H-3, H-4, H-6, Convertible Preferred Stock     3,410,354       338,069  
Restricted shares (unvested)     -       244,643  
Totals     8,018,116       1,549,430